Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study

Affiliations

• ¹ Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium.
• ² Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Anesthesiology Department, Yvoir, Belgium.
• ³ Université catholique de Louvain, CHU UCL Namur, Intensive Care Department, Yvoir, Belgium.
• ⁴ Division of Angiology and Hemostasis - Geneva Platelet Group, Departement of Medicine, Université de Genève et Hôpitaux Universitaires de Genève, Geneva, Switzerland.